Inclusion body myositis (IBM) is the most common acquired myopathy in patients over 50years. The pathology involves an inflammatory response and β-amyloid deposits in muscle fibers. It is believed that MAP kinases such as ERK, JNK and p38 signaling pathways mediate the inflammatory signaling in cells. There is evidence that autophagic activity plays a crucial role in the pathogenesis of IBM. Using an in vitro model of IBM, transcription factors, such as MAP kinases, the autophagic pathway and accumulation of β-amyloid were examined. Rhabdomyosarcoma cells were exposed to the cytokines IFN-γ and IL-1β for 24 and 48h. In addition, the cells were treated with various MAP kinase inhibitors. The protein expression of IL-1β, CXCL9 and of phosphorylated and non-phosphorylated forms of the different MAP kinases was determined by western blotting. The effects on autophagy were analyzed using stably transfected GFP-LC3-rhabdomyosarcoma cells. β-Sheet aggregates were visualized by immunocytochemistry. Cell death was determined via propidium iodide staining. Stimulation of muscle cells with IL-1β and IFN-γ led to an increased phosphorylation of ERK, but neither JNK nor p38. The ERK inhibitor PD98059 diminished the expression of pro-inflammatory markers as well as the accumulation of β-amyloid. Immunocytochemical analysis of GFP-LC3 muscle cells showed that IL-1β and IFN-γ led to an increase of autophagic activity, upregulation of APP and subsequent accumulation of β-sheet aggregates. Taken together, these data demonstrate that MAP kinases, such as ERK are of importance for the formation of β-amyloid and the regulation of autophagic activity in an in vitro model of IBM, especially under conditions of proinflammatory cell stress. Thus, ERK could provide an important link between inflammation and protein deposition. This study contributes to a better understanding of the pathogenesis of chronic muscle inflammation as in IBM.
Read full abstract